Modulation of Apoptotic and Akt/PI3K/mTOR pathways to target Glioblastoma Cells using synthetic compound PGEA-AN

Modulation of Apoptotic and Akt/PI3K/mTOR pathways to target Glioblastoma Cells using synthetic compound PGEA-AN

Show other versions (1)

Objective: To investigate the anticancer potential of a novel synthetic derivative of a naturally occurring diterpenoid against glioblastoma. Method: The in vitro study was conducted at the Ojha Campus of Dow University of Health Sciences, Karachi, from February to December 2021, and comprised U87...

Full description

Bibliographic Details
Main Authors:	Shafea Saad, Farina Hanif, Shabana Usman Simjee, Shaheen Faizi, Lubna Khan, Ambreen Ashfaque
Format:	Article
Language:	English
Published:	Pakistan Medical Association 2024-02-01
Series:	Journal of the Pakistan Medical Association
Online Access:	http://ojs.jpma.org.pk/index.php/public_html/article/view/1163

Similar Items

Modulation of Apoptotic and Akt/PI3K/mTOR pathways to target Glioblastoma Cells using synthetic compound PGEA-AN
by: Shafea Saad, et al.
Published: (2024-02-01)

Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
by: Amir Barzegar Behrooz, et al.
Published: (2022-01-01)

Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway
by: Xiangjin Zheng, et al.
Published: (2021-11-01)

PI3K/AKT/mTOR pathway in Angiogenesis
by: Jayashree eKarar, et al.
Published: (2011-12-01)

Targeting PI3K/Akt/mTOR Signaling In Cancer
by: Camillo ePorta, et al.
Published: (2014-04-01)

PI3K/Akt/mTOR inhibitors in breast cancer
by: Joycelyn JX Lee, et al.
Published: (2015-12-01)

Leukotriene B4 receptor knockdown affects PI3K/AKT/mTOR signaling and apoptotic responses in colorectal cancer
by: Cui Tang, et al.
Published: (2024-01-01)

PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer
by: Kunrui Zhu, et al.
Published: (2022-08-01)

Roles of PI3K/AKT/mTOR Axis in Arteriovenous Fistula
by: Stefano Ratti, et al.
Published: (2022-02-01)

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
by: Eun Jin Sun, et al.
Published: (2021-11-01)

The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma
by: Tasuku Matsuoka, et al.
Published: (2014-07-01)

AKTivation of the PI3K/AKT/mTOR signaling pathway by KSHV
by: Aadra P Bhatt, et al.
Published: (2013-01-01)

A review of photobiomodulation on PI3K/AKT/mTOR in wound healing
by: Patricia Kasowanjete, et al.
Published: (2024-02-01)

Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence
by: Salihanur Darici, et al.
Published: (2020-09-01)

Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
by: Huayi Li, et al.
Published: (2021-07-01)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
by: Jieun Bang, et al.
Published: (2023-08-01)

Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer
by: Carla L. Alves, et al.
Published: (2023-02-01)

The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
by: Ling-Yu Tian, et al.
Published: (2023-01-01)

Targeting the PI3K/Akt/mTOR Signaling Pathway: Applications of Nanotechnology
by: Forough Alemi Serej, et al.
Published: (2018-01-01)

Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
by: R. Reilly, et al.
Published: (2017-08-01)

The PI3K/AKT/mTOR signaling pathway is overactivated in primary aldosteronism.
by: Hengchuan Su, et al.
Published: (2013-01-01)

Oncogenic Ras is downregulated by ARHI and induces autophagy by Ras/AKT/mTOR pathway in glioblastoma
by: Chen Zhong, et al.
Published: (2019-05-01)

Neferine Ameliorates Sepsis-Induced Myocardial Dysfunction Through Anti-Apoptotic and Antioxidative Effects by Regulating the PI3K/AKT/mTOR Signaling Pathway
by: Zhen Qi, et al.
Published: (2021-07-01)

Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
by: Diana-Theodora Morgos, et al.
Published: (2024-02-01)

Downregulation of PI3K/AKT/mTOR Pathway in Juglone-Treated Bovine Oocytes
by: Marwa El-Sheikh, et al.
Published: (2023-01-01)

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
by: Antonino Glaviano, et al.
Published: (2023-08-01)

The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases
by: Amin Iranpanah, et al.
Published: (2023-03-01)

Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
by: Nazanin Momeni Roudsari, et al.
Published: (2021-08-01)

Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy
by: Somayyeh Ghareghomi, et al.
Published: (2023-01-01)

Cyclophosphamide Inhibits PI3K/AKT/mTOR Signaling Pathway in Mice Kidneys
by: Gulsah Albayrak, et al.
Published: (2018-12-01)

Sequential dosing in chemosensitization: targeting the PI3K/Akt/mTOR pathway in neuroblastoma.
by: Mike-Andrew Westhoff, et al.
Published: (2013-01-01)

Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours
by: Fei Xu, et al.
Published: (2020-04-01)

The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
by: Elisavet Paplomata, et al.
Published: (2014-07-01)

Research Progress on PI3K/AKT/mTOR Signaling Pathway in Burkitt Lymphoma
by: SUN Yuanyuan, et al.
Published: (2019-02-01)

Corrigendum: Neferine Ameliorates Sepsis-Induced Myocardial Dysfunction Through Anti-Apoptotic and Antioxidative Effects by Regulating the PI3K/AKT/mTOR Signaling Pathway
by: Zhen Qi, et al.
Published: (2022-04-01)

PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
by: Premila D. Leiphrakpam, et al.
Published: (2024-03-01)

PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities
by: Wojciech Wiese, et al.
Published: (2023-11-01)

PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway
by: Hui Li, et al.
Published: (2023-03-01)

Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
by: Qingfang Li, et al.
Published: (2022-12-01)

Inhibition of the PI3K-Akt-mTOR signaling pathway in T lymphocytes in patients with active tuberculosis
by: XueXuan Zhang, et al.
Published: (2017-06-01)